Healthcare
Biotech Stocks Will Likely Be the Surprise Big Winner Once Again
By Steve Sjuggerud The last truly great “Melt Up” in U.S.
Here Are My Top 3 Biotech Stocks
By Genia Turanova There’s nothing like cash to show how successful a company has been. When a fledgling enterprise first turns cash-flow positive …
3 Small Cap Biotechs with Upcoming Catalysts
Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …
Why Caladrius Biosciences (CLBS) Stock Is Significantly Undervalued
Those that follow my articles know that I tend to focus mainly on undervalued microcap or smallcap biotech companies. A lot of my …
Are These Two Healthcare Stocks Great Bargains? Analysts Say Yes
By Harriet Lefton You don’t need to spend big to pick up premium stock picks… not when you can use the markets’ current …
3 Biotechs with Upcoming Data to Watch
Written by Dan Cohen and Scott Matusow Cytokinetics (NASDASQ:CYTK) looks to turn around their fortunes following last year’s unsuccessful readout of Tirasemtiv in …
Abbvie (ABBV): A Top Winning Stock to Buy
By Amber Hestla This past weekend, I had a chance to talk to a friend who’s been trading financial markets for more than …
Recent Sell-Off in Jounce therapeutics’ (JNCE) Stock Is Unwarranted
Written by Dan Cohen In the wake of recently revealed abstracts from the 2018 ASCO meeting, Jounce therapeutics (NASDAQ:JNCE) stock price recently took …
Omeros (OMER) Stock Could Become a 10-Bagger
By Richard Robinson Many Americans are optimistic about achieving a comfortable retirement. They fund their 401(k) or IRA in hopes of accumulating a nest …
Hedge Fund Tycoon David Shaw Makes 2 Risky Bio Bets: MannKind Corporation (MNKD), Valeant Pharmaceuticals Intl Inc (VRX)
Chief scientist Shaw looks for unusual sources of return in MNKD and VRX.
